VBI Vaccines, Inc. - Ordinary Shares (VBIV)

Pre-market stock movers are a hot topic on Wednesday and we have all of the latest news traders need to know about them this morning!

VBI Vaccines stock is up on Tuesday as shares of VBIV continue to be volatile after the company filed for bankruptcy last week.

We have all of the biggest pre-market stock movers that traders are going to want to read about on Tuesday!

VBIV stock results show that VBI Vaccines missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.

VBIV stock results show that VBI Vaccines beat analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2023.

Shares of Fastenal Company (NASDAQFAST) fell sharply during Thursday’s session following worse-than-expected first-quarter financial results.

Shares of Biophytis S.A. (NASDAQBPTS) rose sharply in today’s pre-market trading after reporting FY23 results.

It's time to dive into all of the biggest pre-market stock movers that traders will want to keep an eye on Friday morning!

Shares of Sony Group Corporation (NYSESONY) fell during Wednesday’s session after the company reported third-quarter financial results and revised guidance above estimates and shared plans to list its financial arm in October 2025.

Shares of Robinhood Markets, Inc. (NASDAQHOOD) shares rose sharply in today’s pre-market trading after the company reported better-than-expected fourth-

Shares of Faraday Future Intelligent Electric Inc. (NASDAQFFIE) surged in pre-market trading after the company announced its foray into the Middle Ea

  On Thursday, 369 companies hit new 52-week lows.

Gainers

The Dow Jones closed higher by more than 300 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Running the gamut from large to small, and from commercial stage to clinical stage, these are seven top biotech stocks to sell in July.

  During the session on Thursday, 461 stocks hit new 52-week lows.

  During Tuesday's session, 275 companies made new 52-week lows.

F-star Therapeutics formed a license agreement with Takeda to develop Fcab domains aimed at undisclosed immuno-oncology targets. Also, Brii Bio signed a global license to an HBV immunotherapeutic therapy developed by VBI Vaccines for $15 million.

  Friday's session saw 169 companies set new 52-week lows.